+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pharmaceutical Continuous Manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • PDF Icon

    Report

  • 145 Pages
  • August 2022
  • Region: Global
  • IMARC Group
  • ID: 5647921
UP TO OFF until Dec 31st 2022
The global pharmaceutical continuous manufacturing market reached a value of US$ 1.05 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 2.24 Billion by 2027, exhibiting a CAGR of 13.46% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Pharmaceutical continuous manufacturing refers to an end-to-end medication production approach that enhances the quality and consistency of various novel drugs and vaccines with minimal capital investments. As compared to batch processing, it operates in a continuous flow, is easier to scale, offers greater control to manufacturers and a higher level of automation, and eliminates physical intervention. Apart from this, pharmaceutical continuous manufacturing aids in minimizing the medicine formulation duration, risk of human errors, monitoring the production procedures, and improving the product quality to harmonize with the regulatory guidelines. Consequently, the technique is extensively utilized by pharmaceutical companies and contract manufacturing organizations (CMOs) to develop active pharmaceutical ingredients (API) and medicines. At present, it is available in integrated, semi-continuous, and control types.

Pharmaceutical Continuous Manufacturing Market Trends:

One of the primary factors currently driving the global pharmaceutical continuous manufacturing market is the increasing demand for effective medicine production systems for composing various effective biologics at a lower cost. This can be further attributed to the rising drug shortages and the growing prevalence of several chronic ailments across the globe. Additionally, the rising health concerns, especially during the coronavirus disease (COVID-19) pandemic outbreak, have prompted pharmaceutical companies to use continuous manufacturing techniques to compose novel vaccines, which is acting as another growth-inducing factor. In line with this, significant technological advancements, such as rapid automation in the pharmaceutical manufacturing methodology and the large-scale integration of artificial intelligence (AI) solutions, are contributing to the market growth. Other factors, such as significant improvements in the pharmaceutical sector, ongoing research and development (R&D) activities, and the escalating awareness about the availability of food and drug administration (FDA) approved medicines, are creating a positive outlook for the market.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global pharmaceutical continuous manufacturing market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on therapeutics type, formulation, application and end user.

Breakup by Therapeutics Type:

  • Large Molecules
  • Small Molecules

Breakup by Formulation:

  • Solid Formulation
  • Liquid and Semi-solid Formulation

Breakup by Application:

  • Final Drug Product Manufacturing
  • API Manufacturing

Breakup by End User:

  • Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Baker Perkins, Coperion GmbH (Hillenbrand Inc.), Eli Lilly and Company, GEA Group Aktiengesellschaft, Glatt GmbH, Korsch AG, Novartis AG, Siemens, SK biotek, Thermo Fisher Scientific Inc. and Viatris Inc.

Key Questions Answered in This Report:

  • How has the global pharmaceutical continuous manufacturing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pharmaceutical continuous manufacturing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the therapeutics type?
  • What is the breakup of the market based on the formulation?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pharmaceutical continuous manufacturing market and who are the key players?
  • What is the degree of competition in the industry?
Frequently Asked Questions about the Global Pharmaceutical Continuous Manufacturing Market

What is the estimated value of the Global Pharmaceutical Continuous Manufacturing Market?

The Global Pharmaceutical Continuous Manufacturing Market was estimated to be valued at $1.05 Billion in 2021.

What is the growth rate of the Global Pharmaceutical Continuous Manufacturing Market?

The growth rate of the Global Pharmaceutical Continuous Manufacturing Market is 13.4%, with an estimated value of $2.24 Billion by 2027.

What is the forecasted size of the Global Pharmaceutical Continuous Manufacturing Market?

The Global Pharmaceutical Continuous Manufacturing Market is estimated to be worth $2.24 Billion by 2027.

Who are the key companies in the Global Pharmaceutical Continuous Manufacturing Market?

Key companies in the Global Pharmaceutical Continuous Manufacturing Market include Baker Perkins, Coperion GmbH (Hillenbrand Inc.), Eli Lilly and Company, GEA Group Aktiengesellschaft, Glatt GmbH, Korsch AG, Novartis AG, Siemens and Thermo Fisher Scientific Inc..

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pharmaceutical Continuous Manufacturing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Therapeutics Type
6.1 Large Molecules
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Small Molecules
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Formulation
7.1 Solid Formulation
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Liquid and Semi-solid Formulation
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Final Drug Product Manufacturing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 API Manufacturing
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by End User
9.1 Pharmaceutical Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Contract Manufacturing Organizations
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Baker Perkins
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Coperion GmbH (Hillenbrand Inc.)
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Eli Lilly and Company
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 GEA Group Aktiengesellschaft
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Glatt GmbH
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Korsch AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Novartis AG
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Siemens
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 SK biotek
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Thermo Fisher Scientific Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Viatris Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
List of Figures
Figure 1: Global: Pharmaceutical Continuous Manufacturing Market: Major Drivers and Challenges
Figure 2: Global: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Therapeutics Type (in %), 2021
Figure 5: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Formulation (in %), 2021
Figure 6: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Application (in %), 2021
Figure 7: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by End User (in %), 2021
Figure 8: Global: Pharmaceutical Continuous Manufacturing Market: Breakup by Region (in %), 2021
Figure 9: Global: Pharmaceutical Continuous Manufacturing (Large Molecules) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Pharmaceutical Continuous Manufacturing (Large Molecules) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Pharmaceutical Continuous Manufacturing (Small Molecules) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Pharmaceutical Continuous Manufacturing (Small Molecules) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Pharmaceutical Continuous Manufacturing (Solid Formulation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Pharmaceutical Continuous Manufacturing (Solid Formulation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Pharmaceutical Continuous Manufacturing (Liquid and Semi-solid Formulation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Pharmaceutical Continuous Manufacturing (Liquid and Semi-solid Formulation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Pharmaceutical Continuous Manufacturing (Final Drug Product Manufacturing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Pharmaceutical Continuous Manufacturing (Final Drug Product Manufacturing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Pharmaceutical Continuous Manufacturing (API Manufacturing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Pharmaceutical Continuous Manufacturing (API Manufacturing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Pharmaceutical Continuous Manufacturing (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Pharmaceutical Continuous Manufacturing (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Pharmaceutical Continuous Manufacturing (Contract Manufacturing Organizations) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Pharmaceutical Continuous Manufacturing (Contract Manufacturing Organizations) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Pharmaceutical Continuous Manufacturing (Others) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Pharmaceutical Continuous Manufacturing (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: North America: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: North America: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: United States: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: United States: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Canada: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Canada: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Asia-Pacific: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Asia-Pacific: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: China: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: China: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Japan: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Japan: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: India: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: India: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: South Korea: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: South Korea: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Australia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Australia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Indonesia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Indonesia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Europe: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Europe: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Germany: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Germany: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: France: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: France: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: United Kingdom: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: United Kingdom: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Italy: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Italy: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Spain: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Spain: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Russia: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Russia: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Latin America: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Latin America: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Brazil: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Brazil: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Mexico: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Mexico: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Others: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Others: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market: Breakup by Country (in %), 2021
Figure 75: Middle East and Africa: Pharmaceutical Continuous Manufacturing Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Global: Pharmaceutical Continuous Manufacturing Industry: SWOT Analysis
Figure 77: Global: Pharmaceutical Continuous Manufacturing Industry: Value Chain Analysis
Figure 78: Global: Pharmaceutical Continuous Manufacturing Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Pharmaceutical Continuous Manufacturing Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Therapeutics Type (in Million US$), 2022-2027
Table 3: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Formulation (in Million US$), 2022-2027
Table 4: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Pharmaceutical Continuous Manufacturing Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Pharmaceutical Continuous Manufacturing Market: Competitive Structure
Table 8: Global: Pharmaceutical Continuous Manufacturing Market: Key Players

Companies Mentioned

  • Baker Perkins
  • Coperion GmbH (Hillenbrand Inc.)
  • Eli Lilly and Company
  • GEA Group Aktiengesellschaft
  • Glatt GmbH
  • Korsch AG
  • Novartis AG
  • Siemens
  • SK biotek
  • Thermo Fisher Scientific Inc.
  • Viatris Inc.

Methodology

Loading
LOADING...